Last update 11 Mar 2026

Anti-EGFR CAR-T cell therapy(Cellular Biomedicine Group, Inc.)

Overview

Basic Info

Drug Type
CAR-T
Synonyms
Anti-EGFR CAR, Anti-EGFR CAR-transduced T-cell therapy, CART-EGFR
+ [2]
Target
EGFR x TGF-β
Action
antagonists, inhibitors
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), TGF-β inhibitors(Transforming growth factor beta inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication
Solid tumor
Originator Organization
AbelZeta Pharma, Inc.AbelZeta Pharma, Inc.
Active Organization
Chinese People's Liberation Army General HospitalChinese People's Liberation Army General HospitalAbelZeta Pharma, Inc.AbelZeta Pharma, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Anti-EGFR CAR-T cell therapy(Cellular Biomedicine Group, Inc.)
Login to view more data
100 Translational Medicine associated with Anti-EGFR CAR-T cell therapy(Cellular Biomedicine Group, Inc.)
Login to view more data
100 Patents (Medical) associated with Anti-EGFR CAR-T cell therapy(Cellular Biomedicine Group, Inc.)
Login to view more data
100 Deals associated with Anti-EGFR CAR-T cell therapy(Cellular Biomedicine Group, Inc.)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Solid tumorPhase 2
China
-10 Apr 2013
NeoplasmsPhase 2
China
Chinese People's Liberation Army General HospitalChinese People's Liberation Army General Hospital
-
NeoplasmsPhase 2
China
AbelZeta Pharma, Inc.AbelZeta Pharma, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free